Pemphigoid with Autoantibodies against p200 and all Subunits of Laminin 332 Associated with Drug Eruption Caused by Piperacillin/tazobactam

Schmidt E, Zillikens D. Pemphigoid diseases. Lancet 2013; 381: 320–332.

https://doi.org/10.1016/S0140-6736(12)61140-4 DOI: https://doi.org/10.1016/S0140-6736(12)61140-4

Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, et al. From anti-p200 pemphigoid to anti-laminin γ1 pemphigoid. J Dermatol 2010; 37: 231–238.

https://doi.org/10.1111/j.1346-8138.2009.00793.x DOI: https://doi.org/10.1111/j.1346-8138.2009.00793.x

Goletz S, Hashimoto T, Zillikens D, Schmidt E. Anti-p200 pemphigoid. J Am Acad Dermatol 2014; 71: 185–191.

https://doi.org/10.1016/j.jaad.2014.02.036 DOI: https://doi.org/10.1016/j.jaad.2014.02.036

Kridin K, Ahmed AR. Anti-p200 pemphigoid: a systematic review. Front Immunol 2019; 10: 2466.

https://doi.org/10.3389/fimmu.2019.02466 DOI: https://doi.org/10.3389/fimmu.2019.02466

Shi L, Li X, Qian H. Anti-laminin 332-type mucous membrane pemphigoid. Biomolecules 2022; 12: 1461.

https://doi.org/10.3390/biom12101461 DOI: https://doi.org/10.3390/biom12101461

Murata S, Sumikawa Y, Takahashi H, Ota M, Kusatake K, Niihara H, et al. Case of mucous membrane pemphigoid with immunoglobulin G antibodies to the beta 3 subunit of laminin-332 showing clinically Stevens–Johnson syndrome-like generalized blistering mucocutaneous lesions. J Dermatol 2015; 42: 1126–1128.

https://doi.org/10.1111/1346-8138.13062 DOI: https://doi.org/10.1111/1346-8138.13062

Sugawara A, Koga H, Tsutsumi M, Ishii N, Nakama T. A case of mucous membrane pemphigoid with anti-laminin alpha 3 and beta 3 antibodies initially mimicking Stevens–Johnson syndrome. Int J Dermatol 2022; 61: e199–e200.

https://doi.org/10.1111/ijd.15714 DOI: https://doi.org/10.1111/ijd.15714

Miralles J, Barnadas MA, Baselga E, Gelpí C, Rodríguez JL, de Moragas JM. Bullous pemphigoid-like lesions induced by amoxicillin. Int J Dermatol 1997; 36: 42–47.

https://doi.org/10.1111/j.1365-4362.1997.tb03302.x DOI: https://doi.org/10.1111/j.1365-4362.1997.tb03302.x

Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol 2020; 100: adv00224.

https://doi.org/10.2340/00015555-3457 DOI: https://doi.org/10.2340/00015555-3457

Goletz S, Pigors M, Lari TR, Hammers CM, Wang Y, Emtenani S, et al. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid. J Am Acad Dermatol 2024; 90: 790–797.

https://doi.org/10.1016/j.jaad.2023.11.014 DOI: https://doi.org/10.1016/j.jaad.2023.11.014

Rose C, Schmidt E, Kerstan A, Thoma-Uszynski S, Wesselmann U, Käsbohrer U, et al. Histopathology of anti-laminin 5 mucous membrane pemphigoid. J Am Acad Dermatol 2009; 61: 433–440.

https://doi.org/10.1016/j.jaad.2009.02.012 DOI: https://doi.org/10.1016/j.jaad.2009.02.012

Li X, Qian H, Ishii N, Yamaya M, Fukuda H, Mukai H, et al. A case of concurrent antilaminin γ1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid. Br J Dermatol 2014; 171: 1257–1259.

https://doi.org/10.1111/bjd.13107 DOI: https://doi.org/10.1111/bjd.13107

Liu W, Sun X, Gao Y, Li H, Shi L, Cheng L, et al. A Chinese case of concurrent anti-laminin γ1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid. J Dermatol 2023; 50: e69–e71.

https://doi.org/10.1111/1346-8138.16513 DOI: https://doi.org/10.1111/1346-8138.16513